Edwards Lifesciences Corp at Bank of America Merrill Lynch Health Care Conference Transcript
This is really meant to be entirely Q&A. So Scott, thank you for being here.
My pleasure.
If there's any kind of overarching message you want to get across, fine. Otherwise, we can just jump right into it.
Well, maybe I'll just make some overview comments to get us started. A couple of things. One, we're off to a good start this year. I think we feel very confident about the future of our therapies aimed at treating aortic stenosis.
And a couple of things have happened early on. One is we saw these extraordinary results of the PARTNER 3 trial looking at patients who were at low risk of undergoing traditional open heart surgery. And that trial showed superiority over traditional open heart surgery. The second element, I guess, is we continue to see just dramatic undertreatment of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |